FANCC (Fanconi anaemia complementation group C)

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Home Genes Leukemias Solid Tumors Cancer-Prone Deep Insight Case Reports Journals Portal Teaching

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

FANCC (Fanconi anaemia complementation group C)

Written	2012-07	Hemantika Dasgupta, Chinmay Kumar Panda
		Chittaranjan National Cancer Institute, 37, S P Mukherjee Road, Kolkata 700026, India

This article is an update of :

	2002-06	Jean-Loup Huret
		Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France

	1998-02	Jean-Loup Huret
		Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France

(Note : for Links provided by Atlas : click)

Identity

Alias (NCBI)	FAC
	FACC
	FA3
HGNC (Hugo)	FANCC
HGNC Alias symb	FAC
	FA3
HGNC Previous name	FACC
HGNC Previous name	Fanconi anemia complementation group C
LocusID (NCBI)	2176
Atlas_Id	101
Location	9q22.32 [Link to chromosome band 9q22]
Location_base_pair	Starts at 95110226 and ends at 95317709 bp from pter ( according to GRCh38/hg38-Dec_2013) [Mapping FANCC.png]
Local_order	Next to PTCH and XPAC !!


	Probe(s) - Courtesy Mariano Rocchi, Resources for Molecular Cytogenetics.

Fusion genes
(updated 2017)

Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands)

	FANCC (9q22.32) / C9orf3 (9q22.32)	FANCC (9q22.32) / DDX31 (9q34.13)	FANCC (9q22.32) / EFL1 (15q25.2)
	FANCC (9q22.32) / NDE1 (16p13.11)	FANCC (9q22.32) / ROR2 (9q22.31)

DNA/RNA

Description	14 exons; spans 80 kb.
Transcription	mRNA of 2.3, 3.2, and 4.6 kb (alternative splicing in 5', variable 3' untranslated region, exon 13 skipping).

Protein

Description	558 amino acids; 63 kDa.
Expression	Wide, in particular in the bones; high expression in proliferating cells, low in differentiated cells.
Localisation	Cytoplasmic (mostly) and nuclear.
Function	- FANCA and FANCG form a complex in the cytoplasm, through a N-term FANCA (involving the nuclear localization signal) - FANCG interaction; FANCC join the complex; phosphorylation of FANCA would induce its translocation into the nucleus. This FA complex translocates into the nucleus, where FANCE and FANCF are present; FANCE and FANCF join the complex. The FA complex subsequently interacts with FANCD2 by monoubiquitination of FANCD2 during S phase or following DNA damage. Activated (ubiquinated ) FANCD2, downstream in the FA pathway, will then interact with other proteins involved in DNA repair, possibly BRCA1; after DNA repair, FANCD2 return to the non-ubiquinated form. - FANCC may have mutlifunctional roles, in addition to its involvement in the FA pathway. FANCC binds to cdc2 (mitotic cyclin-dependent kinase), STAT1, GRP94 (a chaperon protein), NADPH, and a number of other proteins; involved in DNA repair and in suppressing interferon gamma induced cellular apoptosis. There are 15 FA genes that make up the FA pathway. Among these FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCM and FANCL form the core complex. During G1 phase of cell cycle these proteins are localized in the cytoplasm. During S phase or during DNA damage FANCA and FANCG at first form a complex in the cytoplasm followed by its interaction with FANCC. Then the complex translocates to the nucleus. In the nucleus other FA proteins like FANCE, F, B, M and L interact with the complex. They cooperatively bind to form the core complex. FANCL has E3 ubiquitin ligase activity. The core complex then activates FANCD2 and FANCI by monoubiquitination. The activated FANCD2-FANCI complex then interact with other FA genes like FANCP/SLX4, FANCD1/BRCA2, FANCJ/BRIP1 and FANCN/PALB2 for efficient DNA repair. FANCC helps in accumulation of FANCE and it has role in foci formation of MRE11/RAD50/NBS1 complex in response to intrastrand crosslink inducers. FANCC binds to cdc2 (mitotic cyclin-dependent kinase), it is necessary for DNA damage-induced G2/M checkpoint in vitro and in vivo. In response to oxidative DNA damage, FANCC prevents premature senescence in hematopoietic stem cells. It interacts with cytochrome p-450 reductase and NADPH during increased production of reactive oxygen species (ROS). In hematopoietic stem cells it regulates apoptosis, self renewal capacity and cell cycle control. It inhibits activity of dsRNA dependent protein kinase mediated death signaling pathway by interacting with Hsp70. FANCC and p53 cooperatively work in apoptosis. It has role in suppressing interferon gamma induced cellular apoptosis. In normal oral epithelium, a gradual increase of FANCC protein expression from basal to parabasal layer to spinous layer suggesting its role in cellular proliferation and differentiation. FANCC is important for proper functioning of monocytes/macrophages. It suppresses TNFα production in mononuclear phagocytes by suppressing TLR8 activity. FANCC interacts with STAT1, GRP94 (a chaperon protein). It has role in telomere attrition and telomere recombination.
Homology	No known homology.

Mutations

Germinal

Most mutations are found in exon1, intron 4, and exon 14.

Implicated in

Note

Entity	Fanconi anaemia (FA)
Note	FACC is implicated in the FA complementation group C; it represents about 15% of FA cases.
Disease	Fanconi anaemia is a chromosome instability syndrome/cancer prone disease (at risk of leukaemia).
Prognosis	- Fanconi anaemia's prognosis is poor; mean survival is 16 years: patients die of bone marrow failure (infections, haemorrhages), leukaemia, or androgen therapy related liver tumours. - It has recently been shown that significant phenotypic differences were found between the various complementation groups. FA group C patients had less somatic abnormalities. However, there is a certain clinical heterogeneity.
Cytogenetics	Spontaneous,chromatid/chromosome breaks; increased rate of breaks compared to control, when induced by breaking agent.
Hybrid/Mutated Gene	Mutations in exon 4, 13 leading to deletion of exon 9 were reported in Brazilian Fanconi Anemia patients.
Oncogenesis	Fanconi anemia patients are prone to develop head and neck, esophageal, gastrointestinal, vulvar and anal cancers. Frequent deletion and promoter methylation are observed in FANCC gene in oral cancer, breast cancer, acute leukemia and pancreatic cancer.


Entity	Diabetes and obesity
Note	FANCC prevents diabetes and obesity.

To be noted

Apart from its function in DNA damage repair, FANCC plays important role in apoptosis, cell cycle, differentiation and innate immunity.

Bibliography

p38 MAPK inhibition suppresses the TLR-hypersensitive phenotype in FANCC- and FANCA-deficient mononuclear phagocytes.

Anur P, Yates J, Garbati MR, Vanderwerf S, Keeble W, Rathbun K, Hays LE, Tyner JW, Svahn J, Cappelli E, Dufour C, Bagby GC.

Blood. 2012 Mar 1;119(9):1992-2002. Epub 2012 Jan 10.

PMID 22234699

The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features.

Barroso E, Pita G, Arias JI, Menendez P, Zamora P, Blanco M, Benitez J, Ribas G.

Breast Cancer Res Treat. 2009 Dec;118(3):655-60. Epub 2009 Jun 18.

PMID 19536649

Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer.

Berwick M, Satagopan JM, Ben-Porat L, Carlson A, Mah K, Henry R, Diotti R, Milton K, Pujara K, Landers T, Dev Batish S, Morales J, Schindler D, Hanenberg H, Hromas R, Levran O, Auerbach AD.

Cancer Res. 2007 Oct 1;67(19):9591-6.

PMID 17909071

Regulation of the Fanconi anemia group C protein through proteolytic modification.

Brodeur I, Goulet I, Tremblay CS, Charbonneau C, Delisle MC, Godin C, Huard C, Khandjian EW, Buchwald M, Levesque G, Carreau M.

J Biol Chem. 2004 Feb 6;279(6):4713-20. Epub 2003 Nov 18.

PMID 14625294

Breaks at telomeres and TRF2-independent end fusions in Fanconi anemia.

Callen E, Samper E, Ramirez MJ, Creus A, Marcos R, Ortega JJ, Olive T, Badell I, Blasco MA, Surralles J.

Hum Mol Genet. 2002 Feb 15;11(4):439-44.

PMID 11854176

Germ line Fanconi anemia complementation group C mutations and pancreatic cancer.

Couch FJ, Johnson MR, Rabe K, Boardman L, McWilliams R, de Andrade M, Petersen G.

Cancer Res. 2005 Jan 15;65(2):383-6.

PMID 15695377

Molecular biology of Fanconi anemia: implications for diagnosis and therapy.

D'Andrea AD, Grompe M.

Blood. 1997 Sep 1;90(5):1725-36. (REVIEW)

PMID 9292505

Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.

Faivre L, Guardiola P, Lewis C, Dokal I, Ebell W, Zatterale A, Altay C, Poole J, Stones D, Kwee ML, van Weel-Sipman M, Havenga C, Morgan N, de Winter J, Digweed M, Savoia A, Pronk J, de Ravel T, Jansen S, Joenje H, Gluckman E, Mathew CG.

Blood. 2000 Dec 15;96(13):4064-70.

PMID 11110674

Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis.

Freie B, Li X, Ciccone SL, Nawa K, Cooper S, Vogelweid C, Schantz L, Haneline LS, Orazi A, Broxmeyer HE, Lee SH, Clapp DW.

Blood. 2003 Dec 1;102(12):4146-52. Epub 2003 Jul 10.

PMID 12855557

A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint.

Freie BW, Ciccone SL, Li X, Plett PA, Orschell CM, Srour EF, Hanenberg H, Schindler D, Lee SH, Clapp DW.

J Biol Chem. 2004 Dec 3;279(49):50986-93. Epub 2004 Sep 17.

PMID 15377654

Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J, Grompe M, d'Andrea AD.

Mol Cell. 2001 Feb;7(2):249-62.

PMID 11239454

Association of FANCC and PTCH1 with the development of early dysplastic lesions of the head and neck.

Ghosh A, Ghosh S, Maiti GP, Mukherjee S, Mukherjee N, Chakraborty J, Roy A, Roychoudhury S, Panda CK.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S528-38. Epub 2011 Aug 23.

PMID 21861228

Characterisation of the exon structure of the Fanconi anaemia group C gene by vectorette PCR.

Gibson RA, Buchwald M, Roberts RG, Mathew CG.

Hum Mol Genet. 1993 Jan;2(1):35-8.

PMID 8490620

FANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway.

Gordon SM, Alon N, Buchwald M.

J Biol Chem. 2005 Oct 28;280(43):36118-25. Epub 2005 Aug 26.

PMID 16127171

Fanconi anemia and DNA repair.

Grompe M, d'Andrea A.

Hum Mol Genet. 2001 Oct 1;10(20):2253-9. (REVIEW)

PMID 11673408

Lack of self-renewal capacity in Fancc-/- stem cells after ex vivo expansion.

Habi O, Delisle MC, Messier N, Carreau M.

Stem Cells. 2005 Sep;23(8):1135-41. Epub 2005 Jul 14.

PMID 16020692

Human FANCC is hypomorphic in murine Fancc-deficient cells.

Hays LE, Keeble WW, Yates JE, Rathbun RK, Koretsky T, Olson SB, Sun Z, Clapp DW, Bagby GC Jr.

Blood. 2010 Sep 23;116(12):2057-60. Epub 2010 Jun 16.

PMID 20554974

Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia.

Hess CJ, Ameziane N, Schuurhuis GJ, Errami A, Denkers F, Kaspers GJ, Cloos J, Joenje H, Reinhardt D, Ossenkoppele GJ, Zwaan CM, Waisfisz Q.

Cell Oncol. 2008;30(4):299-306.

PMID 18607065

Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM.

Hirano S, Yamamoto K, Ishiai M, Yamazoe M, Seki M, Matsushita N, Ohzeki M, Yamashita YM, Arakawa H, Buerstedde JM, Enomoto T, Takeda S, Thompson LH, Takata M.

EMBO J. 2005 Jan 26;24(2):418-27. Epub 2004 Dec 23.

PMID 15616572

Towards a molecular understanding of the fanconi anemia core complex.

Hodson C, Walden H.

Anemia. 2012;2012:926787. Epub 2012 May 22.

PMID 22675617

Upregulation of Fanconi anemia DNA repair genes in melanoma compared with non-melanoma skin cancer.

Kao WH, Riker AI, Kushwaha DS, Ng K, Enkemann SA, Jove R, Buettner R, Zinn PO, Sanchez NP, Villa JL, d'Andrea AD, Sanchez JL, Kennedy RD, Chen CC, Matta JL.

J Invest Dermatol. 2011 Oct;131(10):2139-42. doi: 10.1038/jid.2011.181. Epub 2011 Jun 23.

PMID 21697891

Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.

Kennedy RD, Chen CC, Stuckert P, Archila EM, De la Vega MA, Moreau LA, Shimamura A, d'Andrea AD.

J Clin Invest. 2007 May;117(5):1440-9. Epub 2007 Apr 12.

PMID 17431503

Association of FANCC polymorphisms with FEV1 decline in aspirin exacerbated respiratory disease.

Kim JH, Park BL, Pasaje CF, Bae JS, Park JS, Park SW, Uh ST, Choi JS, Kim YH, Kim MK, Choi IS, Cho SH, Choi BW, Park CS, Shin HD.

Mol Biol Rep. 2012 Mar;39(3):2385-94. Epub 2011 Jun 14.

PMID 21670957

FANCD1/BRCA2 plays predominant role in the repair of DNA damage induced by ACNU or TMZ.

Kondo N, Takahashi A, Mori E, Noda T, Zdzienicka MZ, Thompson LH, Helleday T, Suzuki M, Kinashi Y, Masunaga S, Ono K, Hasegawa M, Ohnishi T.

PLoS One. 2011 May 9;6(5):e19659.

PMID 21573016

The nuclear accumulation of the Fanconi anemia protein FANCE depends on FANCC.

Leveille F, Ferrer M, Medhurst AL, Laghmani el H, Rooimans MA, Bier P, Steltenpool J, Titus TA, Postlethwait JH, Hoatlin ME, Joenje H, de Winter JP.

DNA Repair (Amst). 2006 May 10;5(5):556-65. Epub 2006 Feb 28.

PMID 16513431

Fanconi anemia links reactive oxygen species to insulin resistance and obesity.

Li J, Sipple J, Maynard S, Mehta PA, Rose SR, Davies SM, Pang Q.

Antioxid Redox Signal. 2012 Oct 15;17(8):1083-98. Epub 2012 Jun 25.

PMID 22482891

Impaired function of Fanconi anemia type C-deficient macrophages.

Liu Y, Ballman K, Li D, Khan S, Derr-Yellin E, Shou W, Haneline LS.

J Leukoc Biol. 2012 Feb;91(2):333-40. Epub 2011 Nov 21.

PMID 22106009

Evidence for subcomplexes in the Fanconi anemia pathway.

Medhurst AL, Laghmani el H, Steltenpool J, Ferrer M, Fontaine C, de Groot J, Rooimans MA, Scheper RJ, Meetei AR, Wang W, Joenje H, de Winter JP.

Blood. 2006 Sep 15;108(6):2072-80. Epub 2006 May 23.

PMID 16720839

The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair.

Niedzwiedz W, Mosedale G, Johnson M, Ong CY, Pace P, Patel KJ.

Mol Cell. 2004 Aug 27;15(4):607-20.

PMID 15327776

Oxidative stress in Fanconi anaemia: from cells and molecules toward prospects in clinical management.

Pagano G, Aiello Talamanca A, Castello G, Pallardo FV, Zatterale A, Degan P.

Biol Chem. 2011 Nov 7. [Epub ahead of print]

PMID 22059913

Fanconi anaemia proteins: major roles in cell protection against oxidative damage.

Pagano G, Youssoufian H.

Bioessays. 2003 Jun;25(6):589-95. (REVIEW)

PMID 12766948

Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents.

Palagyi A, Neveling K, Plinninger U, Ziesch A, Targosz BS, Denk GU, Ochs S, Rizzani A, Meier D, Thasler WE, Hanenberg H, De Toni EN, Bassermann F, Schafer C, Goke B, Schindler D, Gallmeier E.

Mol Cancer. 2010 May 28;9:127.

PMID 20509860

The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC.

Pang Q, Christianson TA, Keeble W, Koretsky T, Bagby GC.

J Biol Chem. 2002 Dec 20;277(51):49638-43. Epub 2002 Oct 22.

PMID 12397061

DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein.

Pichierri P, Averbeck D, Rosselli F.

Hum Mol Genet. 2002 Oct 1;11(21):2531-46.

PMID 12354779

Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner.

Qiao F, Moss A, Kupfer GM.

J Biol Chem. 2001 Jun 29;276(26):23391-6. Epub 2001 Apr 10.

PMID 11297559

FANCC suppresses short telomere-initiated telomere sister chromatid exchange.

Rhee DB, Wang Y, Mizesko M, Zhou F, Haneline L, Liu Y.

Hum Mol Genet. 2010 Mar 1;19(5):879-87. Epub 2009 Dec 18.

PMID 20022886

Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde.

Ridpath JR, Nakamura A, Tano K, Luke AM, Sonoda E, Arakawa H, Buerstedde JM, Gillespie DA, Sale JE, Yamazoe M, Bishop DK, Takata M, Takeda S, Watanabe M, Swenberg JA, Nakamura J.

Cancer Res. 2007 Dec 1;67(23):11117-22.

PMID 18056434

Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma.

Sinha S, Singh RK, Alam N, Roy A, Roychoudhury S, Panda CK.

Mol Cancer. 2008 Nov 6;7:84.

PMID 18990233

Cloning of cDNAs for Fanconi's anaemia by functional complementation.

Strathdee CA, Gavish H, Shannon WR, Buchwald M.

Nature. 1992 Apr 30;356(6372):763-7.

PMID 1574115

BRCA1-independent ubiquitination of FANCD2.

Vandenberg CJ, Gergely F, Ong CY, Pace P, Mallery DL, Hiom K, Patel KJ.

Mol Cell. 2003 Jul;12(1):247-54.

PMID 12887909

TLR8-dependent TNF-(alpha) overexpression in Fanconi anemia group C cells.

Vanderwerf SM, Svahn J, Olson S, Rathbun RK, Harrington C, Yates J, Keeble W, Anderson DC, Anur P, Pereira NF, Pilonetto DV, Pasquini R, Bagby GC.

Blood. 2009 Dec 17;114(26):5290-8. Epub 2009 Oct 22.

PMID 19850743

Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.

Yamashita T, Nakahata T.

Int J Hematol. 2001 Jul;74(1):33-41. (REVIEW)

PMID 11530803

Novel inactivating mutations of FANCC in Brazilian patients with Fanconi anemia.

Yates J, Keeble W, Pals G, Ameziane N, van Spaendonk R, Olson S, Akkari Y, Pasquini R, Bagby G.

Hum Mutat. 2006 Feb;27(2):214.

PMID 16429406

Fanconi anemia C gene product regulates expression of genes involved in differentiation and inflammation.

Zanier R, Briot D, Dugas du Villard JA, Sarasin A, Rosselli F.

Oncogene. 2004 Jun 24;23(29):5004-13.

PMID 15077170

Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence.

Zhang X, Sejas DP, Qiu Y, Williams DA, Pang Q.

J Cell Sci. 2007 May 1;120(Pt 9):1572-83. Epub 2007 Apr 3.

PMID 17405815

Citation

This paper should be referenced as such :

Dasgupta, H ; Panda, CK

FANCC (Fanconi anaemia complementation group C)

Atlas Genet Cytogenet Oncol Haematol. 2013;17(1):17-20.

Free journal version : [ pdf ] [ DOI ]

History of this paper:

Jean-Loup Huret. FACC (Fanconi anaemia complementation group C). Atlas Genet Cytogenet Oncol Haematol. 1998;2(1):10-11.

http://documents.irevues.inist.fr/bitstream/handle/2042/32097/02-1998-FACCID101.pdf

Huret, JL. FACC (Fanconi anaemia complementation group C). Atlas Genet Cytogenet Oncol Haematol. 2002;6(4):275-276.

http://documents.irevues.inist.fr/bitstream/handle/2042/37892/06-2002-FACC101.pdf

Other Solid tumors implicated (Data extracted from papers in the Atlas) [ 3 ]

FANCC/C9orf3 (9q22)
FANCC/ROR2 (9q22)
t(9;9)(q22;q34) FANCC/DDX31

Other Cancer prone implicated (Data extracted from papers in the Atlas) [ 2 ]

Fanconi anemia Familial Myeloproliferative Disorders

External links

	Nomenclature
HGNC (Hugo)	FANCC 3584
LRG (Locus Reference Genomic)	LRG_497
	Cards
Atlas	FACCID101
Entrez_Gene (NCBI)	FANCC FA complementation group C
Aliases	FA3; FAC; FACC
GeneCards (Weizmann)	FANCC
Ensembl hg19 (Hinxton)	ENSG00000158169 [Gene_View]
Ensembl hg38 (Hinxton)	ENSG00000158169 [Gene_View] ENSG00000158169 [Sequence] chr9:95110226-95317709 [Contig_View] FANCC [Vega]
ICGC DataPortal	ENSG00000158169
TCGA cBioPortal	FANCC
AceView (NCBI)	FANCC
Genatlas (Paris)	FANCC
SOURCE (Princeton)	FANCC
Genetics Home Reference (NIH)	FANCC
	Genomic and cartography
GoldenPath hg38 (UCSC)	FANCC - chr9:95110226-95317709 - 9q22.32 [Description] (hg38-Dec_2013)
GoldenPath hg19 (UCSC)	FANCC - 9q22.32 [Description] (hg19-Feb_2009)
GoldenPath	FANCC - 9q22.32 [CytoView hg19] FANCC - 9q22.32 [CytoView hg38]
ImmunoBase	ENSG00000158169
genome Data Viewer NCBI	FANCC [Mapview hg19]
OMIM	227645 613899
	Gene and transcription
Genbank (Entrez)	AI280997 AK222871 AK304887 AK310599 AK312548
RefSeq transcript (Entrez)	NM_000136 NM_001243743 NM_001243744
RefSeq genomic (Entrez)
Consensus coding sequences : CCDS (NCBI)	FANCC
Alternative Splicing Gallery	ENSG00000158169
Gene Expression	FANCC [ NCBI-GEO ] FANCC [ EBI - ARRAY_EXPRESS ] FANCC [ SEEK ] FANCC [ MEM ]
Gene Expression Viewer (FireBrowse)	FANCC [ Firebrowse - Broad ]
Genevisible	Expression of FANCC in : [tissues] [cell-lines] [cancer] [perturbations]
BioGPS (Tissue expression)	2176
GTEX Portal (Tissue expression)	FANCC
Human Protein Atlas	ENSG00000158169-FANCC [pathology] [cell] [tissue]
	Protein : pattern, domain, 3D structure
UniProt/SwissProt	Q00597 [function] [subcellular_location] [family_and_domains] [pathology_and_biotech] [ptm_processing] [expression] [interaction]
NextProt	Q00597 [Sequence] [Exons] [Medical] [Publications]
With graphics : InterPro	Q00597
Splice isoforms : SwissVar	Q00597
PhosPhoSitePlus	Q00597
Domains : Interpro (EBI)	FANCC
Domain families : Pfam (Sanger)	Fanconi_C (PF02106)
Domain families : Pfam (NCBI)	pfam02106
Conserved Domain (NCBI)	FANCC
Blocks (Seattle)	FANCC
Superfamily	Q00597
Human Protein Atlas [tissue]	ENSG00000158169-FANCC [tissue]
Peptide Atlas	Q00597
HPRD	01967
IPI	IPI00023608 IPI00745713 IPI00645428
	Protein Interaction databases
DIP (DOE-UCLA)	Q00597
IntAct (EBI)	Q00597
BioGRID	FANCC
STRING (EMBL)	FANCC
ZODIAC	FANCC
	Ontologies - Pathways
QuickGO	Q00597
Ontology : AmiGO	myeloid cell homeostasis protein binding nucleus nucleoplasm cytoplasm cytosol DNA repair nucleotide-excision repair germ cell development removal of superoxide radicals cellular response to oxidative stress interstrand cross-link repair Fanconi anaemia nuclear complex Fanconi anaemia nuclear complex brain morphogenesis protein-containing complex assembly neuronal stem cell population maintenance
Ontology : EGO-EBI	myeloid cell homeostasis protein binding nucleus nucleoplasm cytoplasm cytosol DNA repair nucleotide-excision repair germ cell development removal of superoxide radicals cellular response to oxidative stress interstrand cross-link repair Fanconi anaemia nuclear complex Fanconi anaemia nuclear complex brain morphogenesis protein-containing complex assembly neuronal stem cell population maintenance
Pathways : KEGG	Fanconi anemia pathway
REACTOME	Q00597 [protein]
REACTOME Pathways	R-HSA-6796648 [pathway]
NDEx Network	FANCC
Atlas of Cancer Signalling Network	FANCC
Wikipedia pathways	FANCC
	Orthology - Evolution
OrthoDB	2176
GeneTree (enSembl)	ENSG00000158169
Phylogenetic Trees/Animal Genes : TreeFam	FANCC
HOGENOM	Q00597
Homologs : HomoloGene	FANCC
Homology/Alignments : Family Browser (UCSC)	FANCC
	Gene fusions - Rearrangements
Fusion : Mitelman	FANCC/C9orf3 [9q22.32/9q22.32]
Fusion : Mitelman	FANCC/DDX31 [9q22.32/9q34.13]
Fusion : Mitelman	FANCC/ROR2 [9q22.32/9q22.31]
Fusion Portal	FANCC 9q22.32 C9orf3 9q22.32 HNSC
Fusion Portal	FANCC 9q22.32 DDX31 9q34.13 LGG
Fusion Portal	FANCC 9q22.32 ROR2 9q22.31 PRAD
Fusion : Fusion_Hub	DIAPH1--FANCC EGFR--FANCC FANCC--ACTG2 FANCC--C20ORF112 FANCC--C9ORF3 FANCC--DDX31 FANCC--EPB41L2 FANCC--ERCC6L2 FANCC--NDE1 FANCC--PLGRKT FANCC--PSIP1 FANCC--ROR2
Fusion : Quiver	FANCC
	Polymorphisms : SNP and Copy number variants
NCBI Variation Viewer	FANCC [hg38]
dbVar	FANCC
ClinVar	FANCC
Monarch	FANCC
1000_Genomes	FANCC
Exome Variant Server	FANCC
GNOMAD Browser	ENSG00000158169
Varsome Browser	FANCC
Genomic Variants (DGV)	FANCC [DGVbeta]
DECIPHER	FANCC [patients] [syndromes] [variants] [genes]
CONAN: Copy Number Analysis	FANCC
	Mutations
ICGC Data Portal	FANCC
TCGA Data Portal	FANCC
Broad Tumor Portal	FANCC
OASIS Portal	FANCC [ Somatic mutations - Copy number]
Cancer Gene: Census	FANCC
Somatic Mutations in Cancer : COSMIC	FANCC [overview] [genome browser] [tissue] [distribution]
Somatic Mutations in Cancer : COSMIC3D	FANCC
Mutations and Diseases : HGMD	FANCC
LOVD (Leiden Open Variation Database)	Whole genome datasets
LOVD (Leiden Open Variation Database)	LOVD - Leiden Open Variation Database
LOVD (Leiden Open Variation Database)	LOVD 3.0 shared installation
LOVD (Leiden Open Variation Database)	PUBLIC CCHMC Molecular Genetics Laboratory Mutation Database
LOVD (Leiden Open Variation Database)	Fanconi anemia database
BioMuta	search FANCC
DgiDB (Drug Gene Interaction Database)	FANCC
DoCM (Curated mutations)	FANCC (select the gene name)
CIViC (Clinical Interpretations of Variants in Cancer)	FANCC (select a term)
intoGen	FANCC
OncoKB	FANCC
NCG6 (London)	select FANCC
Cancer3D	FANCC(select the gene name)
Impact of mutations	[PolyPhen2] [Provean] [Buck Institute : MutDB] [Mutation Assessor] [Mutanalyser]
	Diseases
OMIM	227645 613899
Orphanet	634
DisGeNET	FANCC
Medgen	FANCC
Genetic Testing Registry	FANCC
NextProt	Q00597 [Medical]
GENETests	FANCC
Target Validation	FANCC
Huge Navigator	FANCC [HugePedia]
ClinGen	FANCC
	Clinical trials, drugs, therapy
MyCancerGenome	FANCC
Protein Interactions : CTD
Pharm GKB Gene	PA27997
Pharos	Q00597
Clinical trial	FANCC
	Miscellaneous
canSAR (ICR)	FANCC (select the gene name)
Harmonizome	FANCC
DataMed Index	FANCC
	Probes
	Litterature
PubMed	146 Pubmed reference(s) in Entrez
GeneRIFs	Gene References Into Functions (Entrez)
EVEX	FANCC

REVIEW articles	automatic search in PubMed
Last year publications	automatic search in PubMed

Search in all EBI NCBI

indexed on : Fri Feb 19 17:50:27 CET 2021

Home Genes Leukemias Solid Tumors Cancer-Prone Deep Insight Case Reports Journals Portal Teaching

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.